Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas

BackgroundTumor necrosis and apoptotic activity are considered important in cancer progression, but these features have not been much studied in melanomas. Our hypothesis was that rapid growth in cutaneous melanomas of the vertical growth phase might lead to tissue hypoxia, alterations in apoptotic activity and tumor necrosis. We proposed that these tumor characteristics might be associated with changes in expression of cell adhesion proteins leading to increased invasive capacity and reduced patient survival.MethodsA well characterized series of nodular melanoma (originally 202 cases) and other benign and malignant melanocytic tumors (109 cases) were examined for the presence of necrosis, apoptotic activity (TUNEL assay), immunohistochemical expression of hypoxia markers (HIF-1 α, CAIX, TNF-α, Apaf-1) and cell adhesion proteins (αvβ3 integrin, CD44/HCAM and osteopontin). We hypothesized that tumor hypoxia and necrosis might be associated with increased invasiveness in melanoma through alterations of tumor cell adhesion proteins.ResultsNecrosis was present in 29% of nodular melanomas and was associated with increased tumor thickness, tumor ulceration, vascular invasion, higher tumor proliferation and apoptotic index, increased expression of αvβ3 integrin and poor patient outcome by multivariate analysis. Tumor cell apoptosis did also correlate with reduced patient survival. Expression of TNF-α and Apaf-1 was significantly associated with tumor thickness, and osteopontin expression correlated with increased tumor cell proliferation (Ki-67).ConclusionTumor necrosis and apoptotic activity are important features of melanoma progression and prognosis, at least partly through alterations in cell adhesion molecules such as increased αvβ3 integrin expression, revealing potentially important targets for new therapeutic approaches to be further explored.

[1]  L. Akslen,et al.  Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  Holger Moch,et al.  Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade , 2001, The Journal of pathology.

[3]  M. Herlyn,et al.  Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. , 2000, Journal of cell science.

[4]  A. Harris,et al.  Hypoxia Inducible Carbonic Anhydrase IX, Marker of Tumour: Hypoxia, Survival Pathway and Therapy Target , 2004, Cell cycle.

[5]  F. Mitjans,et al.  In vivo therapy of malignant melanoma by means of antagonists of alphav integrins. , 2000, International journal of cancer.

[6]  F. Mitjans,et al.  In vivo therapy of malignant melanoma by means of antagonists of αv integrins , 2000 .

[7]  T. Koji,et al.  Fas-Mediated Apoptosis of Melanoma Cells and Infiltrating Lymphocytes in Human Malignant Melanomas , 2002, Modern Pathology.

[8]  K. Nakanishi,et al.  Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  M. Noda,et al.  Osteopontin‐Deficiency Suppresses Growth of B16 Melanoma Cells Implanted in Bone and Osteoclastogenesis in Co‐Cultures , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  M. Nosrati,et al.  Osteopontin as a molecular prognostic marker for melanoma , 2008, Cancer.

[11]  A. Harris,et al.  Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  A. Baldi,et al.  Role of Apaf‐1, a key regulator of apoptosis, in melanoma progression and chemoresistance , 2005, Experimental dermatology.

[13]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[14]  A. Harris,et al.  Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. , 2001, Cancer research.

[15]  P. Kincade,et al.  CD44 and its interaction with extracellular matrix. , 1993, Advances in immunology.

[16]  E. Mooney,et al.  Apoptotic and mitotic indices in malignant melanoma and basal cell carcinoma. , 1995, Journal of clinical pathology.

[17]  V. Kosma,et al.  Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma. , 2000, The American journal of pathology.

[18]  L. Akslen,et al.  Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma , 1997, International journal of cancer.

[19]  A. Harris,et al.  The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages , 2000 .

[20]  L. Akslen,et al.  Angiogenesis is prognostically important in vertical growth phase melanomas. , 1999, International journal of oncology.

[21]  W. Sly,et al.  Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. , 2001, The American journal of pathology.

[22]  D. Elder,et al.  Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. , 1998, The American journal of pathology.

[23]  D. Lev,et al.  Cellular Adhesion Pathways and Metastatic Potential of Human Melanoma , 2002, Cancer biology & therapy.

[24]  L. Akslen,et al.  Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression. , 2002, The American journal of pathology.

[25]  J. Simon,et al.  High CD44 surface expression on primary tumours of malignant melanoma correlates with increased metastatic risk and reduced survival. , 1997, European journal of cancer.

[26]  J. Heino,et al.  αV integrin promotes in vitro and in vivo survival of cells in metastatic melanoma , 2004, International journal of cancer.

[27]  P. Vaupel,et al.  Hypoxia in cancer: significance and impact on clinical outcome , 2007, Cancer and Metastasis Reviews.

[28]  L. Skoog,et al.  Expression of CD40, CD44, bcl‐2 antigens and rate of cell proliferation on fine needle aspirates from metastatic melanoma , 2002, Cytopathology : official journal of the British Society for Clinical Cytology.

[29]  M. Martinka,et al.  Reduced Apaf-1 expression in human cutaneous melanomas , 2004, British Journal of Cancer.

[30]  L. Akslen,et al.  Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas. , 2001, The American journal of pathology.

[31]  K. Niedojadło,et al.  Apaf-1 expression in human cutaneous melanoma progression and in pigmented nevi. , 2006, Pigment cell research.

[32]  F. Mitjans,et al.  Alpha v integrin antagonists induce the disassembly of focal contacts in melanoma cells. , 2000, European journal of cell biology.

[33]  P. Bonnier,et al.  Overexpression of hypoxia‐inducible factor HIF‐1α predicts early relapse in breast cancer: Retrospective study in a series of 745 patients , 2005, International journal of cancer.

[34]  E. Rofstad,et al.  The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products. , 2005, Cancer research.

[35]  A. Shilkaitis,et al.  Beta3 integrin expression in melanoma predicts subsequent metastasis. , 1996, The Journal of surgical research.

[36]  John Calvin Reed Apoptosis-targeted therapies for cancer. , 2003, Cancer cell.

[37]  A. Harris,et al.  Hypoxia‐inducible factor‐1α in non small cell lung cancer: Relation to growth factor, protease and apoptosis pathways , 2004, International journal of cancer.

[38]  R. Hofmann-Wellenhof,et al.  CD44 and variants in melanocytic skin neoplasms , 1998, Journal of cutaneous pathology.

[39]  A Breslow,et al.  Thickness, Cross‐Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma , 1970, Annals of surgery.

[40]  M. Ringuette,et al.  Novel Functions of the Matricellular Proteins Osteopontin and Osteonectin/SPARC , 2002, Connective tissue research.

[41]  G. Botti,et al.  Analysis of APAF‐1 expression in human cutaneous melanoma progression , 2004, Experimental dermatology.

[42]  D. Hedley,et al.  Expression of hypoxia-inducible factor-1alpha in cervical carcinomas: correlation with tumor oxygenation. , 2002, International journal of radiation oncology, biology, physics.

[43]  D. Elder,et al.  Progression-related expression of beta3 integrin in melanomas and nevi. , 1999, Human pathology.

[44]  E. Raso,et al.  Role for beta3 integrins in human melanoma growth and survival. , 2002, International journal of cancer.

[45]  D. Denhardt Osteopontin expression correlates with melanoma invasion. , 2005, The Journal of investigative dermatology.

[46]  M. Herlyn,et al.  Hsu M, Andl T, Li G, Meinkoth JL, Herlyn MCadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J Cell Sci 113: 1535-1542 , 2000 .

[47]  K. Nakanishi,et al.  Expression of Hypoxia-Inducible Factor-1α Protein Predicts Survival in Patients with Transitional Cell Carcinoma of the Upper Urinary Tract , 2005, Clinical Cancer Research.

[48]  W. Clark,et al.  The histogenesis and biologic behavior of primary human malignant melanomas of the skin. , 1969, Cancer research.

[49]  L. Akslen,et al.  Importance of P-Cadherin, β-Catenin, and Wnt5a/Frizzled for Progression of Melanocytic Tumors and Prognosis in Cutaneous Melanoma , 2005, Clinical Cancer Research.

[50]  Ichikawa,et al.  Moesin and CD44 expression in cutaneous melanocytic tumours , 1998, The British journal of dermatology.

[51]  E. Raso,et al.  Role for β3 integrins in human melanoma growth and survival , 2002 .

[52]  Karen D. Cowden Dahl,et al.  Hypoxia-inducible factor regulates alphavbeta3 integrin cell surface expression. , 2005, Molecular biology of the cell.

[53]  J. Heino,et al.  Integrin chains beta1 and alphav as prognostic factors in human metastatic melanoma. , 2004, Melanoma research.